Phreesia, Inc. (NYSE:PHR) General Counsel Sells $86,955.60 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,495 shares of the business’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the completion of the transaction, the general counsel now directly owns 116,296 shares of the company’s stock, valued at approximately $2,893,444.48. This trade represents a 2.92 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Phreesia Price Performance

Shares of Phreesia stock opened at $23.84 on Friday. The stock has a market capitalization of $1.39 billion, a P/E ratio of -16.22 and a beta of 0.98. The business has a 50 day simple moving average of $20.73 and a two-hundred day simple moving average of $21.91. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period in the prior year, the company earned ($0.58) EPS. The firm’s revenue was up 16.6% compared to the same quarter last year. As a group, analysts predict that Phreesia, Inc. will post -1.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the business. Champlain Investment Partners LLC grew its stake in Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after purchasing an additional 42,973 shares during the last quarter. State Street Corp grew its position in shares of Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after purchasing an additional 55,934 shares during the last quarter. Finally, TimesSquare Capital Management LLC lifted its position in Phreesia by 2.3% during the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock worth $19,791,000 after buying an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Truist Financial lifted their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Canaccord Genuity Group reiterated a “buy” rating and issued a $34.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Robert W. Baird dropped their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 11th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.